NTLA
Intellia Therapeutics
CRISPR gene editing in vivo therapeutics
$14.07
90d: -1.5%
Updated 31 May 2026, 07:59 UTC · ← Synthetic Biology
👁️
Showcase mode. This page will require a Premium subscription (£70/month) once subscriptions launch. Full company intelligence is shown here so you can see exactly what you'll get. Request early access →
🔒
Premium Intelligence — Previewing Now
This company intelligence brief will be behind the Premium tier (£70/month) when subscriptions launch. You're seeing a full preview below.
What Premium includes
✓ Full intelligence brief for all 42+ tracked companies
✓ AI interrogation of 56,000+ article corpus
✓ Real-time Telegram alerts when NTLA is flagged
✓ Swap proposals with full signal reasoning
✓ Private market watchlist access
Request Early Access → ← Back to Synthetic Biology